Molecular Remission Induced by Gemtuzumab Ozogamicin Associated With Donor Lymphocyte Infusions in T(4;11) Acute Lymphoblastic Leukemia Relapsed After Transplantation
Leukemia - United Kingdom
doi 10.1038/sj.leu.2403134
Full Text
Open PDFAbstract
Available in full text
Date
September 4, 2003
Authors
Publisher
Springer Science and Business Media LLC